PHILIPPINE NATIONAL DRUG

POLICY
(PNDP)

ALEJANDRO V. PINEDA, JR., MD, DFM,

FPAFP
NATIONAL DRUG POLICY
The National Drug Policy(NDP)
is a policy and program of the
national government to ensure
that safe and effective drugs
are made available to all
Filipinos at any time and place
and at a reasonable and
affordable cost.
5 PILLARS
 A. Quality Assurance of
Drugs-

 The quality assurance of safe

and
effective pharmaceutical
products
through control is a basic
 This pillar requires the regulation
of
the importation,manufacture,
marketing, and consumer
utilization
of all pharmaceutical products.

 This is the task of the BFAD.

 B. Rational Use of Drugs by
Health Professionals and
Consumers-

 The promotion of the rational

use
of drugs by health
professionals
and consumers.
 C. National Self-Sufficiency in
Pharmaceuticals-

 Development of national self-

sufficiency in drug
manufacturing
 D. Rationalization of the DOH’s
Procurement Program

 Designed to achieve economies

of bulk purchasing and enhance
the impact of DOH resources.
 E. People Empowerment

 Cuts across all 4 pillars

 Aims to assist people in

exercising
an informed choice in the
purchase
of cost-effective medicines.
OBJECTIVES OF THE
NATIONAL DRUG
POLICY
1.To assure the quality of
drugs and medicines, the
DOH is strengthening the
capabilities of BFAD to
undertake quality control,
product of registration, and
licensing of sales
establishments.
2. To ensure the rational use of
drugs by consumers and health
professionals, the following are
underway:

a. The passage of bills in

Congress requiring generic

labeling, prescribing, and
b. The creation of the
National Drug Policy
Formulary by the
National Drug Committee.

c. The regulation of the

advertising and promotion
of pharmaceutical
products.
3.To achieve self-sufficiency in
basic manufacturing, a
fundamental plan is being
developed with the
participation of the United
Nations Industrial
Development
Organization(UNIDO).
 Based on this plan, private
investment will be given
incentives to produce raw
materials and intermediate of
pharmaceutical products.
4.To rationalize DOH
procurement of
medicines, purchases have
been
based on generic
nomenclature.
Essential Drug List
(EDL)

The EDL is a concept

promoted by the World Health
Organization and refers to
those drug which cure the vast
majority of illnesses and
should be affordable and
available to all persons.
NATIONAL DRUG FORMULARY
(NDF)
 list of medicines officially
recognized and approved by the
DOH.

 core list of medicines considered

essential and a complementary
list of drugs considered useful is
not essential.
 GENERICS ACT OF 1988

REPUBLIC ACT NO. 6675

AN ACT TO PROMOTE, REQUIRE

AND ENSURE THE PRODUCTION OF
AN ADEQUATE SUPPLY,
DISTRIBUTION, USE AND
ACCEPTANCE OF DRUGS AND
MEDICINES IDENTIFIED BY THEIR
GENERIC NAMES.
 GENERIC NAMES

A generic name is a simpler

term for the scientifically-
recognized active ingredient of
a drug.

Paracetamol is a medicine to
control fever. Brand names of
paracetamol include: Tempra,
Biogesic and Tylenol.
 GENERICS ACT OF 1988

STATEMENT OF POLICY

1. To promote, encourage and require the

use of generic terminology in the
importation, manufacture, distribution,
marketing, advertising and promotion,
prescription and dispensing of drugs;
 STATEMENT OF POLICY

2. To ensure the adequate supply of

drugs with generic names at the lowest
possible cost and endeavor to make
them available for free to indigent
patients.
 STATEMENT OF POLICY

3. To encourage the extensive use of

drugs with generic names through a
rational system or procurement and
distribution;
 STATEMENT OF POLICY

4. To emphasize the scientific basis for

the use of drugs, in order that health
professionals may become more aware
and cognizant of their therapeutic
effectiveness, and
 STATEMENT OF POLICY

4. To promote drug safety by minimizing

duplication medications and / or use of
drugs with potentially adverse drug
reactions.
 PENALTY

Any person who shall violate the

use of generic names shall suffer
the penalty graduate
hereunder,vis:

1. For the first conviction, he shall

suffer the penalty of reprimand
which shall be officially recorded in
the appropriate books of the
Professional Regulation
 PENALT
Y
2. For the second conviction,
the penalty of fine in the
amount of not less than two
thousand pesos(P2000) but
not exceeding five thousand
pesos(P5000) at the
discretion of the court;
 PENALTY
3. For the third conviction, the
penalty of fine in the amount
of not less than five thousand
pesos(P5000) but not
exceeding ten thousand
pesos(P10,000) and
suspension of his license to
practice his profession for 30
days at the discretion of the
court;
 PENALTY

4. For the fourth and

subsequent convictions, the
penalty of fine not less than
ten thousand pesos(P10,000)
and suspension of his license
to practice his profession for 1
year or longer at the discretion
of the court.
PHILIPPINE NATIONAL DRUG
FORMULARY
ESSENTIAL DRUGS LIST
Volume I, 5th Edition 2000